vimarsana.com

Latest Breaking News On - Stock incentive - Page 3 : vimarsana.com

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of a restricted.

Syros pharmaceuticalsNasdaq listing ruleStock incentive

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMatteo trottaCompany board of directorsExecutive vice presidentGeneral managerStock incentiveNasdaq listing ruleNorth america

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMatteo trottaCompany board of directorsExecutive vice presidentGeneral managerStock incentiveNasdaq listing ruleNorth america

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WILMINGTON, Del. (BUSINESS WIRE) Mar 29, 2024

United statesMatteo trottaCompany board of directorsExecutive vice presidentGeneral managerStock incentiveNasdaq listing ruleNorth americaBusiness wire

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer

WALTHAM, Mass., March 27, 2024 Dyne Therapeutics, Inc. , a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically.

Johng coxAmy reillyDyne therapeutics incCompensation committee of dyneChief executive officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global select marketStock incentive

vimarsana © 2020. All Rights Reserved.